Keeping Checkpoint Inhibitors in Check-Reference-Cited by-同舟云学术

Keeping Checkpoint Inhibitors in Check

Published:2019-05-03 Issue:5 Volume:2 Page:e192546
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Catenacci Daniel V. T.¹²,Hochster Howard³,Klempner Samuel J.⁴

Affiliation:

1. Department of Medicine-Hematology/Oncology, The University of Chicago Medical Center, Chicago, Illinois

2. Associate Editor, JAMA Network Open

3. Rutgers Cancer Institute of New Jersey, New Brunswick

4. The Angeles Clinic and Research Institute, Los Angeles, California

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/2/5/e192546/17552965/catenacci_2019_ic_190029.pdf

Reference7 articles.

1. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs.;Haslam;JAMA Netw Open,2019

2. Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology.;Marquart;JAMA Oncol,2018

3. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC.;Antonia;N Engl J Med,2018

4. Cost-effectiveness and budgetary consequence analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the US health care system;Criss;JAMA Oncol

5. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.;Shitara;Lancet,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy;Biomaterials;2024-04

2. Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy;Nature Communications;2023-11-09

3. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy;Nature Nanotechnology;2021-08-12

4. The Incorporation of Immunotherapy and Targeted Therapy Into Chemoradiation for Cervical Cancer: A Focused Review;Frontiers in Oncology;2021-05-26

5. Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors;JAMA Network Open;2020-10-23